|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 43.49 USD | -0.16% |
|
+10.13% | +9.93% |
| 07-30 | Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing | MT |
| 07-28 | UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 2,212 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 12.48% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,060 | 1,986 | 1,891 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 10% | -3.6% | -4.76% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 412x | 104x | 62.6x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 3.82x | 3.4x | 2.98x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -3x | 0x | 0.9x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 3.65x | 3.25x | 2.89x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 3.4x | 2.92x | 2.47x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 23.5x | 19.5x | 15.3x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 180x | 79.5x | 44.5x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 38.8x | 49.6x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 2.58% | 2.02% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1056 | 0.4186 | 0.6946 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.2 | 679.6 | 764.6 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.49 | 101.7 | 124 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.51 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.112 | 20.78 | 35.22 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -152.1 | -226.3 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 43.49 | 43.49 | 43.49 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 2/15/22 | 2/21/23 | 2/15/24 | 2/12/25 | 2/17/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 412.58x | 3.4x | 23.59x | -.--% | 2.22B | |
| 31.83x | 4.29x | 16.61x | 2.32% | 192B | |
| 20.57x | 3.56x | 12.52x | 3.28% | 116B | |
| 17.2x | 0.2x | 12.44x | 0.76% | 59.95B | |
| 31.77x | 7.93x | 20.18x | 1.25% | 54.64B | |
| 37.93x | 3.42x | 11.71x | 2.14% | 50B | |
| 36.4x | 6.41x | 20.11x | -.--% | 34.26B | |
| 46.2x | 1.31x | 12.01x | 0.16% | 31.15B | |
| 41.08x | 7.2x | 25.83x | 0.26% | 24.79B | |
| 20.67x | 3.12x | 11.69x | 1.41% | 24.07B | |
| Average | 69.62x | 4.08x | 16.67x | 1.16% | 58.92B | |
| Weighted average by Cap. | 31.02x | 4.03x | 15.47x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
